About WAS/WASL-interacting protein family member 2
WAS/WASL-interacting protein family member 2 (WIPF2) is a protein
from Homo sapiens identified by UniProt accession
Q8TF74, 440 residues long.
MolForge cross-references it against 0 known binders and
48 disease associations.
Target properties
| Protein name | WAS/WASL-interacting protein family member 2 |
| UniProt accession | Q8TF74 |
| Gene | WIPF2 |
| Organism | Homo sapiens |
| Length | 440 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (48)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.44
- multiple sclerosis · score 0.35
- lysosomal storage disease · score 0.35
- Alzheimer disease · score 0.35
- Parkinson disease · score 0.35
- endometrial cancer · score 0.18
- breast adenocarcinoma · score 0.18
- hair color · score 0.16
- appendicular lean mass · score 0.13
- head and neck squamous cell carcinoma · score 0.11
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8TF74-F1 | alphafold | PREDICTED | 59.66 | — |
Amino-acid sequence (440 residues)
MPIPPPPPPP PGPPPPPTFH QANTEQPKLS RDEQRGRGAL LQDICKGTKL KKVTNINDRS APILEKPKGS SGGYGSGGAA LQPKGGLFQG GVLKLRPVGA KDGSENLAGK PALQIPSSRA AAPRPPVSAA SGRPQDDTDS SRASLPELPR MQRPSLPDLS RPNTTSSTGM KHSSSAPPPP PPGRRANAPP TPLPMHSSKA PAYNREKPLP PTPGQRLHPG REGPPAPPPV KPPPSPVNIR TGPSGQSLAP PPPPYRQPPG VPNGPSSPTN ESAPELPQRH NSLHRKTPGP VRGLAPPPPT SASPSLLSNR PPPPARDPPS RGAAPPPPPP VIRNGARDAP PPPPPYRMHG SEPPSRGKPP PPPSRTPAGP PPPPPPPLRN GHRDSITTVR SFLDDFESKY SFHPVEDFPA PEEYKHFQRI YPSKTNRAAR GAPPLPPILR
Explore WAS/WASL-interacting protein family member 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets